Stable liquid formulations of antibodies

Details for Australian Patent Application No. 2006202688 (hide)

Owner Genentech, Inc. Novartis AG

Inventors Arvinte, Tudor; Fauquex, Pierre Francois

Agent Davies Collison Cave

Pub. Number AU-B-2006202688

Parent 2002321055

Filing date 23 June 2006

Wipo publication date 13 July 2006

Acceptance publication date 22 January 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

Event Publications

13 July 2006 Application Open to Public Inspection

  Published as AU-B-2006202688

13 July 2006 Complete Application Filed

22 January 2009 Application Accepted

  Published as AU-B-2006202688

21 May 2009 Standard Patent Sealed

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006202689-Multilayer coextruded films including frangible intralaminar bonding forces

2006202687-Key loading systems and methods